A new study of almost 80,000 children living in urban areas of Catalonia has, for the first time, analysed the relationship between urban exposures and BMI growth trajectories
Read moreBHV Partners, the first venture builder in the southern European health sector, has moved its headquarters to the Barcelona Science Park, and closes an investment round, raising half a million euros. ...
Read moreMinoryx Therapeutics, a Phase 3 clinical stage biotech company focused on the development of differentiating treatment options in orphan central nervous system (CNS) disorders, today announces that th...
Read moreGalecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company developing therapeutics that are designed to target the biological processes that lie at the heart of fibrosis and impact a broad r...
Read moreThe life science company Sartorius successfully closed the acquisition of the Slovenian purification specialist BIA Separations. The transaction was completed on November 2, 2020, after receiving the ...
Read moreVaxdyn – compañía fundada desde el Grupo de “Enfermedades Infecciosas” del Instituto de Biomedicina de Sevilla; MiWEndo Solutions y Gate2Brain se suman a las 8 empresas que actualmente form...
Read morePlants experience different abiotic/biotic stresses, which trigger their molecular machinery to cope with them. Besides general mechanisms prompted by many stresses, specific mechanisms have been intr...
Read moreFlomics Biotech, a startup from the Barcelona Biomedical Research Park (PRBB) operating in the genomics and liquid biopsy fields is excited to announce the launch of its seed investment round of 500.0...
Read moreAtrys Health (BME:ATRY), compañía española que brinda servicios de diagnóstico y tratamiento médico de precisión y pionera en los ámbitos de la telemedicina y de la radioterapia de última gene...
Read moreYsios Capital, a leading Spanish biotechnology venture capital firm, today announced that its portfolio company Galecto Inc. has priced its initial public offering (IPO) and is trading on the Nasdaq G...
Read moreLa compañía biofarmacéutica UCB acaba de anunciar la adquisición de Handl Therapeutics BV, una compañía que desarrolla terapia génica transformadora y de rápido crecimiento, con sede en Lovain...
Read moreGracias a la ayuda Plataformas del Instituto de Salud Carlos III del Ministerio de Ciencia e Innovación
Read more